Literature DB >> 11958866

Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y.

A Vezzani1, M Michalkiewicz, T Michalkiewicz, D Moneta, T Ravizza, C Richichi, M Aliprandi, F Mulé, L Pirona, M Gobbi, C Schwarzer, G Sperk.   

Abstract

Functional studies in epileptic tissue indicate that neuropeptide Y and some of its peptide analogs potently inhibit seizure activity. We investigated seizure susceptibility in transgenic rats overexpressing the rat neuropeptide Y gene under the control of its natural promoter. Seizures were induced in adult transgenic male rats and their wild-type littermates by i.c.v. injection of 0.3 microg kainic acid or by electrical kindling of the dorsal hippocampus. Transgenic rats showed a significant reduction in the number and duration of electroencephalographic seizures induced by kainate by 30% and 55% respectively (P<0.05 and 0.01). Transgenic rats were also less susceptible to epileptogenesis than wild-type littermates as demonstrated by a 65% increase in the number of electrical stimuli required to induce stage 5 seizures (P<0.01). This phenotype was associated with a strong and specific expression of neuropeptide Y mRNA in area CA1, a brain area involved in the seizure network. We conclude that endogenous neuropeptide Y overexpression in the rat hippocampus is associated with inhibition of seizures and epileptogenesis suggesting that this system may be a valuable target for developing novel antiepileptic treatments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958866     DOI: 10.1016/s0306-4522(01)00581-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

2.  Neuropeptide Y and Y1 receptors in kindling epileptogenesis.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

3.  Gene therapy in epilepsy.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

Review 4.  Neuropeptide Y in the recurrent mossy fiber pathway.

Authors:  J Victor Nadler; Bin Tu; Olga Timofeeva; Yiqun Jiao; Herbert Herzog
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

5.  Microarray analysis of postictal transcriptional regulation of neuropeptides.

Authors:  Dawn N Wilson; Hyokwon Chung; Robert C Elliott; Eric Bremer; David George; Sookyong Koh
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.

Authors:  S Foti; R P Haberman; R J Samulski; T J McCown
Journal:  Gene Ther       Date:  2007-08-23       Impact factor: 5.250

7.  The genetics of status epilepticus.

Authors:  Paula Elyse Schauwecker
Journal:  Epilepsia       Date:  2009-12       Impact factor: 5.864

8.  Knockdown and overexpression of NR1 modulates NMDA receptor function.

Authors:  Maggie L Kalev-Zylinska; Wymond Symes; Deborah Young; Matthew J During
Journal:  Mol Cell Neurosci       Date:  2009-04-24       Impact factor: 4.314

Review 9.  How do seizures stop?

Authors:  Fred A Lado; Solomon L Moshé
Journal:  Epilepsia       Date:  2008-05-21       Impact factor: 5.864

10.  Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.

Authors:  Andreas T Sørensen; Litsa Nikitidou; Marco Ledri; En-Ju D Lin; Matthew J During; Irene Kanter-Schlifke; Merab Kokaia
Journal:  Exp Neurol       Date:  2008-11-10       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.